Value Bridge — UNIVERSITY OF MARYLAND MED SYS
Current $-92M → Target $-52M (+$40.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-92.5M
Current EBITDA
$-51.6M
Target EBITDA
+$40.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$9.2M
Payer Mix Optimization
$22.2M
Cost to Collect Reduction
$7.4M
Clean Claim Improvement
$5.5M
Volume & Rate Growth
$37.0M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-92M to $-52M. The highest-impact lever is Volume & Rate Growth at $14.8M probability-weighted.
IC talking point: "We see $41M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $450M in equity value creation."